{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:07:49Z","timestamp":1789744069923,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartlungcirc.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.hlc.2016.08.003","type":"journal-article","created":{"date-parts":[[2016,9,18]],"date-time":"2016-09-18T16:15:12Z","timestamp":1474215312000},"page":"442-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Plasma Serotonin in Heart Failure: Possible Marker and Potential Treatment Target"],"prefix":"10.1016","volume":"26","author":[{"given":"Ahmed M.","family":"Selim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitasha","family":"Sarswat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iosif","family":"Kelesidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Zolty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.hlc.2016.08.003_bib0100","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.hlc.2016.08.003_bib0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0197-0186(94)90150-3","article-title":"5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates","volume":"25","author":"Saudou","year":"1994","journal-title":"Neurochem Int."},{"issue":"17","key":"10.1016\/j.hlc.2016.08.003_bib0110","doi-asserted-by":"crossref","first-page":"9508","DOI":"10.1073\/pnas.97.17.9508","article-title":"Serotonin 2B receptor is required for heart development","volume":"97","author":"Nebigil","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"10.1016\/j.hlc.2016.08.003_bib0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00210-007-0179-1","article-title":"Cardiovascular responses produced by 5-hydroxytriptamine: a pharmacological update on the receptors\/mechanisms involved and therapeutic implications","volume":"376","author":"Villal\u00f3n","year":"2007","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.hlc.2016.08.003_bib0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.108.180976","article-title":"Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy","volume":"104","author":"Jaffr\u00e9","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2016.08.003_bib0125","first-page":"198","article-title":"Patients\u2019 self-assessment of their congestive heart failure: part II: Content, reliability and validity of a new measure. The Minnesota Living with Heart Failure Questionnaire","volume":"3","author":"Rector","year":"1987","journal-title":"Heart Failure"},{"issue":"12","key":"10.1016\/j.hlc.2016.08.003_bib0130","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.4065\/81.12.1603","article-title":"Understanding the basics of cardiopulmonary exercise testing","volume":"81","author":"Milani","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.hlc.2016.08.003_bib0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","article-title":"Increased plasma serotonin in primary pulmonary hypertension","volume":"99","author":"Herve","year":"1995","journal-title":"Am J Med."},{"issue":"8","key":"10.1016\/j.hlc.2016.08.003_bib0140","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/eurjhf\/hfp087","article-title":"Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure","volume":"11","author":"Kjekshus","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.hlc.2016.08.003_bib0145","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1540-8159.2010.02792.x","article-title":"The role of the selective serotonin re-uptake inhibitor sertraline in nondepressive patients with chronic ischemic heart failure: a preliminary study","volume":"33","author":"Leftheriotis","year":"2010","journal-title":"Pacing Clin Electrophysiol."},{"issue":"2","key":"10.1016\/j.hlc.2016.08.003_bib0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bjp.0706966","article-title":"Effects of treatment with a 5-HT4 receptor antagonist in heart failure","volume":"150","author":"Birkeland","year":"2007","journal-title":"Br J Pharmacol."},{"issue":"2","key":"10.1016\/j.hlc.2016.08.003_bib0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/HYPERTENSIONAHA.107.105551","article-title":"Serotonin 5-HT(2B) receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in mice","volume":"52","author":"Monassier","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2016.08.003_bib0160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000205962","article-title":"Disrupted Serotonergic and Sympathoadrenal Systems in Patients with Chronic Heart Failure May Serve as New Therapeutic Targets and Novel Biomarkers to Assess Severity, Progression and Response to Treatment","volume":"113","author":"Razina","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.hlc.2016.08.003_bib0165","doi-asserted-by":"crossref","first-page":"874","DOI":"10.5551\/jat.8995","article-title":"Serotonin levels in platelet-poor plasma and whole blood from healthy subjects: relationship with lipid markers and coronary heart disease risk score","volume":"18","author":"Hirowatari","year":"2011","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.hlc.2016.08.003_bib0170","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.amjcard.2005.03.044","article-title":"Comparison of plasma serotonin levels in patients with variant angina pectoris versus healed myocardial infarction","volume":"96","author":"Figueras","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"9146","key":"10.1016\/j.hlc.2016.08.003_bib0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2016.08.003_bib0180","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomized intervention trial in congestive heart failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.hlc.2016.08.003_bib0185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1016\/j.hlc.2016.08.003_bib0190","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med."}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950616315839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950616315839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T09:53:56Z","timestamp":1536400436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950616315839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1443950616315839"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2016.08.003","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma Serotonin in Heart Failure: Possible Marker and Potential Treatment Target","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2016.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}